QQQ   359.61 (-2.90%)
AAPL   142.01 (-2.31%)
MSFT   285.02 (-3.11%)
FB   339.24 (-4.06%)
GOOGL   2,709.56 (-3.97%)
TSLA   778.00 (-1.69%)
AMZN   3,294.14 (-3.28%)
NVDA   207.06 (-4.40%)
BABA   150.39 (+0.14%)
NIO   35.13 (-4.46%)
CGC   14.20 (-3.47%)
GE   105.13 (-0.21%)
MU   73.40 (-2.37%)
AMD   102.41 (-5.32%)
T   27.21 (-0.69%)
F   14.38 (+1.55%)
ACB   6.78 (+6.10%)
DIS   174.34 (-2.20%)
PFE   42.87 (-1.61%)
BA   218.77 (-2.40%)
AMC   37.53 (-4.50%)
QQQ   359.61 (-2.90%)
AAPL   142.01 (-2.31%)
MSFT   285.02 (-3.11%)
FB   339.24 (-4.06%)
GOOGL   2,709.56 (-3.97%)
TSLA   778.00 (-1.69%)
AMZN   3,294.14 (-3.28%)
NVDA   207.06 (-4.40%)
BABA   150.39 (+0.14%)
NIO   35.13 (-4.46%)
CGC   14.20 (-3.47%)
GE   105.13 (-0.21%)
MU   73.40 (-2.37%)
AMD   102.41 (-5.32%)
T   27.21 (-0.69%)
F   14.38 (+1.55%)
ACB   6.78 (+6.10%)
DIS   174.34 (-2.20%)
PFE   42.87 (-1.61%)
BA   218.77 (-2.40%)
AMC   37.53 (-4.50%)
QQQ   359.61 (-2.90%)
AAPL   142.01 (-2.31%)
MSFT   285.02 (-3.11%)
FB   339.24 (-4.06%)
GOOGL   2,709.56 (-3.97%)
TSLA   778.00 (-1.69%)
AMZN   3,294.14 (-3.28%)
NVDA   207.06 (-4.40%)
BABA   150.39 (+0.14%)
NIO   35.13 (-4.46%)
CGC   14.20 (-3.47%)
GE   105.13 (-0.21%)
MU   73.40 (-2.37%)
AMD   102.41 (-5.32%)
T   27.21 (-0.69%)
F   14.38 (+1.55%)
ACB   6.78 (+6.10%)
DIS   174.34 (-2.20%)
PFE   42.87 (-1.61%)
BA   218.77 (-2.40%)
AMC   37.53 (-4.50%)
QQQ   359.61 (-2.90%)
AAPL   142.01 (-2.31%)
MSFT   285.02 (-3.11%)
FB   339.24 (-4.06%)
GOOGL   2,709.56 (-3.97%)
TSLA   778.00 (-1.69%)
AMZN   3,294.14 (-3.28%)
NVDA   207.06 (-4.40%)
BABA   150.39 (+0.14%)
NIO   35.13 (-4.46%)
CGC   14.20 (-3.47%)
GE   105.13 (-0.21%)
MU   73.40 (-2.37%)
AMD   102.41 (-5.32%)
T   27.21 (-0.69%)
F   14.38 (+1.55%)
ACB   6.78 (+6.10%)
DIS   174.34 (-2.20%)
PFE   42.87 (-1.61%)
BA   218.77 (-2.40%)
AMC   37.53 (-4.50%)
NASDAQ:HSAQ

Health Sciences Acquisitions Co. 2 Short Interest Ratio and Short Volume

$9.83
+0.01 (+0.10 %)
(As of 09/28/2021 03:45 AM ET)
Add
Compare
Today's Range
$9.83
$9.83
50-Day Range
$9.74
$10.00
52-Week Range
$9.68
$14.66
Volume208 shs
Average Volume39,929 shs
Market Capitalization$201.02 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Short Interest Data

Current Short Volume1,700 shares
Previous Short Volume100 shares
Change Vs. Previous Month+1,600.00%
Dollar Volume Sold Short$16,643.00
Short Interest Ratio / Days to Cover0.1
Last Record DateAugust, 31 2021
Outstanding Shares20,450,000 shares
Float Size15,470,000 shares
Short Percent of Float0.01%
Today's Trading Volume208 shares
Average Trading Volume39,929 shares
Today's Volume Vs. Average-99.48%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Health Sciences Acquisitions Co. 2 ?

Sign up to receive the latest short interest report for Health Sciences Acquisitions Co. 2 and its competitors with MarketBeat's FREE newsletter.

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/20211,700 shares $16,643.00 +1,600.0%0.0%0.1 $9.79
8/13/2021100 shares $989.00 -94.1%N/A0 $9.89
7/30/20211,700 shares $16,847.00 -69.6%0.0%0 $9.91
7/15/20215,600 shares $56,280.00 +40.0%0.0%0.2 $10.05
6/30/20214,000 shares $40,800.00 +400.0%0.0%0.1 $10.20
6/15/2021800 shares $8,208.00 -27.3%0.0%0 $10.26
5/28/20211,100 shares $11,296.45 -87.2%0.0%0 $10.27
5/14/20218,600 shares $88,064.00 -62.1%0.1%0.2 $10.24
4/30/202122,700 shares $247,884.00 +682.8%0.1%0.5 $10.92
4/15/20212,900 shares $30,450.00 -74.8%0.0%0.1 $10.50
3/31/202111,500 shares $118,450.00 +15.0%0.1%0.2 $10.30
3/15/202110,000 shares $115,000.00 +35.1%0.1%0.2 $11.50
2/26/20217,400 shares $95,682.00 -26.7%0.1%0.1 $12.93
2/12/202110,100 shares $144,531.00 +1,162.5%0.1%0.2 $14.31
1/29/2021800 shares $9,320.00 -81.0%0.0%0 $11.65
1/15/20214,200 shares $53,130.00 No Change0.0%0.2 $12.65

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Short Interest FAQ

speech bubbles
speech bubbles











Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Short Interest Frequently Asked Questions

What is Health Sciences Acquisitions Co. 2's current short interest?

Short interest is the volume of Health Sciences Acquisitions Co. 2 shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 1,700 shares of HSAQ short. 0.01% of Health Sciences Acquisitions Co. 2's shares are currently sold short. Learn More on Health Sciences Acquisitions Co. 2's current short interest.

What is a good short interest percentage for Health Sciences Acquisitions Co. 2?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of Health Sciences Acquisitions Co. 2's floating shares are currently sold short.

Is Health Sciences Acquisitions Co. 2's short interest increasing or decreasing?

Health Sciences Acquisitions Co. 2 saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 1,700 shares, an increase of 1,600.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Health Sciences Acquisitions Co. 2's float size?

Health Sciences Acquisitions Co. 2 currently has issued a total of 20,450,000 shares. Some of Health Sciences Acquisitions Co. 2's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Health Sciences Acquisitions Co. 2 currently has a public float of 15,470,000 shares.

How does Health Sciences Acquisitions Co. 2's short interest compare to its competitors?

0.01% of Health Sciences Acquisitions Co. 2's shares are currently sold short. Here is how the short interest of companies in the industry of "holding & other investment offices" compare to Health Sciences Acquisitions Co. 2: Fortress Value Acquisition Corp. IV (0.00%), Nautilus Biotechnology, Inc. (10.48%), Avanti Acquisition Corp. (0.08%), Liberty Media Acquisition Co. (0.31%), RedBall Acquisition Corp. (0.77%), MSD Acquisition Corp. (0.04%), Lazard Growth Acquisition Corp. I (0.03%), Horizon Acquisition Co. (0.31%), Gores Holdings VII, Inc. (0.16%), and Churchill Capital Corp VI (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

What does it mean to sell short Health Sciences Acquisitions Co. 2 stock?

Short selling HSAQ is an investing strategy that aims to generate trading profit from Health Sciences Acquisitions Co. 2 as its price is falling. Health Sciences Acquisitions Co. 2's stock is trading up $0.01 today. To short Health Sciences Acquisitions Co. 2 stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Health Sciences Acquisitions Co. 2 will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Health Sciences Acquisitions Co. 2?

A short squeeze for Health Sciences Acquisitions Co. 2 occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HSAQ, which in turn drives the price of the stock up even further.

How often is Health Sciences Acquisitions Co. 2's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HSAQ, twice per month. The most recent reporting period available is August, 31 2021.



This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.